"cancer biomarker" trang 5 - tải miễn phí từ tailieunhanh
Prognostic implication and functional exploration for microRNA-20a as a molecular biomarker of gastrointestinal cancer

Prognostic implication and functional exploration for microRNA-20a as a molecular biomarker of gastrointestinal cancer
14    73    0
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer

Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer
10    63    0
The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy

The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy
12    64    0
Exploring serum and immunoglobulin G Nglycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women

Exploring serum and immunoglobulin G Nglycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women
18    72    0
The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: A systematic review with meta-analysis

The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: A systematic review with meta-analysis
10    88    0
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
9    90    0
Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway

Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway
14    78    0
MicroRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

MicroRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
8    81    0
Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy

Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy
15    85    0
Prognostic and clinicopathological significance of MLKL expression in cancer patients: A meta-analysis

Prognostic and clinicopathological significance of MLKL expression in cancer patients: A meta-analysis
10    82    0
Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis
9    64    0
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer

Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer
19    91    0
Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
9    91    0
Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer

Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer
8    21    1
The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
11    63    1
KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy
11    34    1
An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy
10    41    1
Selection of opioids for cancer-related pain using a biomarker: A randomized, multiinstitutional, open-label trial (RELIEF study)

Selection of opioids for cancer-related pain using a biomarker: A randomized, multiinstitutional, open-label trial (RELIEF study)
6    87    1
Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes

Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes
12    73    1
Effect of neoadjuvant therapy on breast cancer biomarker profile

Effect of neoadjuvant therapy on breast cancer biomarker profile
9    64    1